SAN FRANCISCO (GenomeWeb News) – The 31st Annual JP Morgan Healthcare Conference kicked off here yesterday with several life science tools and diagnostic firms making presentations to investors and other attendees.

The following are capsules from the presentations and breakout sessions of Myriad Genetics, Bruker, Genomic Health, Qiagen, and Waters.

Myriad Genetics

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.